Skip to Content
Skip to Content

Cheminės medžiagos vertinimas. Koreguojamasis Bendrijos veiksmų planas (CoRAP)

Cheminės medžiagos vertinimas. Koreguojamasis Bendrijos veiksmų planas (CoRAP)

For each substance, the table shows the evaluating Member State, the year of evaluation and a short description of the concern which led to it being placed on the list.

Community rolling action plan (CoRAP): The community rolling action plan covers three consecutive years and is updated mid of March every year. From this it follows that substances in the table below with the column ‘Year’ indicating a current or future year, are those that have been prioritised for evaluation, and are effectively on the current CoRAP.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation and CoRAP table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

  • Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
  • CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
  • Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
  • Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
  • Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
  • RCR: Risk Characterisation Ratio
Last updated 09 gruodis 2019. Database contains 375 unique substances/entries.
Filter the list
Initial grounds for concern:

 
222-182-2
3380-34-5
2012
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
206-420-2
338-83-0
2020
Belgium
Suspected PBT/vPvB
Exposure of environment
Not started
Details
222-020-0
3319-31-1
2012
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
221-975-0
3302-10-1
2020
Spain
Suspected Reprotoxic
Exposure of workers
Not started
Details
206-354-4
330-54-1
2014
Finland
Potential endocrine disruptor
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
251-118-6
32588-76-4
2017
Norway
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
2021
France
Suspected Mutagenic
Potential endocrine disruptor
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
251-020-3
32388-55-9
2021
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Not started
Details
250-610-8
31394-54-4
2012
Latvia
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
221-375-9
3081-14-9
2012
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
221-374-3
3081-01-4
2012
Austria
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
931-292-6
308062-28-4
2020
Ireland
Suspected Reprotoxic
Other hazard based concern
Not started
Details
435-790-1
297730-93-9
2018
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
249-820-2
29736-75-2
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Other hazard based concern
Exposure of workers
Ongoing
Details
249-535-3
29253-36-9
2020
Austria
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
206-022-9
288-88-0
2015
Belgium
Suspected CMR
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
206-019-2
288-32-4
2012
United Kingdom
CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
249-204-3
28768-32-3
2013
Denmark
CMR
Wide dispersive use
Information requested
Details
249-044-4
28472-97-1
2013
Italy
Consumer use
High (aggregated) tonnage
Suspected PBT/vPvB
Wide dispersive use
Information requested
Details
248-948-6
28299-41-4
2014
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Follow-up
Details
220-562-2
2814-77-9
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
248-666-3
27813-02-1
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
220-449-8
2768-02-7
2013
Sweden
Suspected Sensitiser
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Follow-up
Details
248-258-5
27138-31-4
2019
Latvia
Suspected Reprotoxic
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
248-227-6
27107-89-7
2021
Netherlands
Potential endocrine disruptor
Not started
Details
220-260-0
2691-41-0
2020
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Not started
Details
247-979-2
26761-45-5
2015
Denmark
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
247-722-4
26471-62-5
2012
Poland
CMR
Suspected PBT/vPvB
Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
247-660-8
26401-35-4
2013
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
247-426-5
26040-51-7
2019
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Ongoing
Details
247-156-8
25640-78-2
Germany
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
401-850-9
255881-94-8
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Follow-up
Details
247-118-0
25584-83-2
2021
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Not started
Details
246-835-6
25321-09-9
2020
France
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
219-785-8
2530-85-0
2015
Ireland
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
246-678-3
25155-25-3
2015
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
246-677-8
25155-23-1
2014
Italy
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Suspected PBT/vPvB
Wide dispersive use
Follow-up
Details
246-563-8
25013-16-5
2015
France
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
Wide dispersive use
Suspended
Details
429-320-2
24748-23-0
2019
Netherlands
PBT/vPvB
Ongoing
Details
219-514-3
2451-62-9
2015
Poland
CMR
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
627-083-1
244235-47-0
2015
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
219-470-5
2440-22-4
2016
Czech Republic
Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
219-372-2
2425-85-6
2019
Germany
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
219-207-4
2386-87-0
2013
Ireland
Suspected CMR
Sensitiser
Exposure of workers
High RCR
Concluded
Details
432-520-2
232938-43-1
2020
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Not started
Details
219-006-1
2312-35-8
2019
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Ongoing
Details
245-366-4
22984-54-9
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
218-747-8
2224-33-1
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
218-645-3
2210-79-9
2016
Denmark
Mutagenic
Information requested
Details
244-617-5
21850-44-2
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details

Export search results to:

Categories Display

Pažymėta kaip:

(spustelėkite žymę norėdami ieškoti atitinkamo turinio)


Route: .live2